Skip to main content


Drug shortage leaves patients without immune-disorder treatment

By The Wall Street Journal  
   August 09, 2019

A shortage of a versatile medicine used to treat immune disorders and other diseases has forced U.S. hospitals and infusion clinics to suspend treatment for many patients. The medicine, immune globulin, contains antibodies harvested from plasma, a component of blood. 

Full story

Get the latest on healthcare leadership in your inbox.